Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02526173 · ClinicalTrials.gov registry record · NA
DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 230
- Enrollment target
NCT02526173 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 230 participants.
The verdict
NCT02526173, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 230 participants
- Enrollment target
Study Summary
The investigators will examine the beneficial impacts of applying of dHACM on the preserved neurovascular bundles (cavernosal nerves) and the prostate bed during robotic assisted laparoscopic prostatectomy. Such application can result in promotion of soft tissue healing and reduction of inflammation at the operative site and thus an acceleration of return of potency regulating cavernosal nerves.
Interventions
- PROCEDURE RALP using full nerve sparing technique
- OTHER dHACM Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2018-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02526173
The ClinicalTrials.gov registry entry for NCT02526173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which RALP using full nerve sparing technique is the first listed.
NCT02526173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02526173 about?
NCT02526173 is a clinical study titled "DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)". The investigators will examine the beneficial impacts of applying of dHACM on the preserved neurovascular bundles (cavernosal nerves) and the prostate bed during robotic assisted laparoscopic prostatectomy. Such application can result in promotion of soft tissue healing and reduction of inflammation...
What is the current status of trial NCT02526173?
This trial is currently completed. It is a NA study. The enrollment target is 230 participants. The study started on 2015-10-01. Estimated completion is 2018-06-21.
What interventions are being tested in trial NCT02526173?
The interventions under investigation include: RALP using full nerve sparing technique (PROCEDURE), dHACM Application (OTHER).
Who is sponsoring clinical trial NCT02526173?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.